These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19291151)

  • 1. The measurement of psychotic acuity by nursing staff.
    Theodoridou C; Bowers L; Brennan G; Gilbert D; Winship G
    J Psychiatr Ment Health Nurs; 2009 Apr; 16(3):234-41. PubMed ID: 19291151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
    Fernandez HH; Aarsland D; Fénelon G; Friedman JH; Marsh L; Tröster AI; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
    Mov Disord; 2008 Mar; 23(4):484-500. PubMed ID: 18175343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Nursing Observed Illness Intensity Scale (NOIIS).
    Bowers L; Brennan G; Ransom S; Winship G; Theodoridou C
    J Psychiatr Ment Health Nurs; 2011 Feb; 18(1):28-34. PubMed ID: 21214681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity and reliability study of the Thai version of WHO schedules for clinical assessment in neuropsychiatry: sections on psychotic disorders.
    Paholpak S; Arunpongpaisal S; Krisanaprakornkit T; Khiewyoo J
    J Med Assoc Thai; 2008 Mar; 91(3):408-16. PubMed ID: 18575297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies surrounding the diagnosis of schizophrenia and other psychoses.
    Cuesta MJ; Basterra V; Sanchez-Torres A; Peralta V
    Expert Rev Neurother; 2009 Oct; 9(10):1475-86. PubMed ID: 19831837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Computerized Assessment System for Psychotherapy Evaluation and Research (CASPER) interview with a psychiatric inpatient population.
    Strong JE; Farrell AD
    J Clin Psychol; 2003 Sep; 59(9):967-84. PubMed ID: 12945062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the brief core schema scales with individuals at clinical high risk of psychosis.
    Addington J; Tran L
    Behav Cogn Psychother; 2009 Mar; 37(2):227-31. PubMed ID: 19364422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are GAF scores reliable in routine clinical use?
    Vatnaland T; Vatnaland J; Friis S; Opjordsmoen S
    Acta Psychiatr Scand; 2007 Apr; 115(4):326-30. PubMed ID: 17355524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of Recovery Scale (LORS): psychometric properties of a new instrument to assess psychotic symptoms and patient awareness.
    Corriveau DP; Sousa S
    Psychol Rep; 2013 Oct; 113(2):435-40. PubMed ID: 24597439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appraisals of Anomalous Experiences Interview (AANEX): a multidimensional measure of psychological responses to anomalies associated with psychosis.
    Brett CM; Peters EP; Johns LC; Tabraham P; Valmaggia LR; McGuire P
    Br J Psychiatry Suppl; 2007 Dec; 51():s23-30. PubMed ID: 18055934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nurse-rating of psychotic behaviour.
    Downing AR; Brockington IF
    J Adv Nurs; 1978 Nov; 3(6):551-62. PubMed ID: 252534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating psychotic patients from nonpsychotic patients with the MMPI-2 and Rorschach.
    Dao TK; Prevatt F; Horne HL
    J Pers Assess; 2008 Jan; 90(1):93-101. PubMed ID: 18444100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and Psychosis Project: a multi-centre European study on comorbidity.
    Baldacchino A; Blair H; Scherbaum N; Grosse-Vehne E; Riglietta M; Tidone L; Criaco C; Marelli MC; Sommer B; Tan L; Little H; Ghodse H
    Drug Alcohol Rev; 2009 Jul; 28(4):379-89. PubMed ID: 19594792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anger and functioning amongst inpatients with schizophrenia or schizoaffective disorder living in a therapeutic community.
    Fassino S; Amianto F; Gastaldo L; Leombruni P
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):186-94. PubMed ID: 19335389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission.
    Alenius M; Hammarlund-Udenaes M; Hartvig P; Sundquist S; Lindström L
    Compr Psychiatry; 2009; 50(5):453-62. PubMed ID: 19683616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
    Velligan DI; Alphs L; Lancaster S; Morlock R; Mintz J
    Psychiatry Res; 2009 Sep; 169(2):97-100. PubMed ID: 19664826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anomalous subjective experience and psychosis risk in young depressed patients.
    Szily E; Kéri S
    Psychopathology; 2009; 42(4):229-35. PubMed ID: 19451755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of Usher's syndrome associated with psychotic symptoms: diagnosis and follow-up in a psychiatric unit].
    Viala A; Nicot T; Levy F; Vacheron MN
    Encephale; 2009 Jun; 35(3):286-91. PubMed ID: 19540416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attachment theory: a framework for understanding symptoms and interpersonal relationships in psychosis.
    Berry K; Barrowclough C; Wearden A
    Behav Res Ther; 2008 Dec; 46(12):1275-82. PubMed ID: 18926521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.